(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CALIBER I.D.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CALIBER I.D.

ST13

US500000086381677

Class

9, 10, 42

Filing

86381677

Registration

4771782

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

03/26/2026

Trademark type

Word

Nice classes

9, 10, 42

Filing date

08/29/2014

Registration date

07/14/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/26/2026

Last transaction

03/26/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2012-11-00

First use in commerce

2012-11-00

Drawing code

4

Owner type

03

Owner location

ROCHESTER, NY, US

Examiner

YAO, GRETTA

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CALIBER IMAGING & DIAGNOSTICS, INC.
Lucid, Inc.

Representatives

Kenneth J. LuKacher KENNETH J. LUKACHER LAW GROUP

Technical classification

Nice Classes

Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Confocal microscopes for clinical examinations in hospitals and by health care professionalsmedical imagers which communicate images of tissue specifically for use by medical personnel for pathological examinations over telephone lines and networks for telemedicine and telepathology applications

Class 10

Optical instruments for use by medical personnel in the examination of disorders of the skin

Class 42

Providing on-line telepathology servicesthe display of images of tissuerelated information and datauseful for examination and diagnosis of such tissue

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/26/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/26/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/26/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/26/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

01/13/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/14/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/18/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/18/2022

E815

TEAS SECTION 8 & 15 RECEIVED

01/14/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

01/10/2022

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

11/04/2021

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

10/22/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/22/2021

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

07/14/2021

E815

TEAS SECTION 8 & 15 RECEIVED

07/14/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2015

PUBO

PUBLISHED FOR OPPOSITION

04/28/2015

NPUB

NOTICE OF PUBLICATION

04/08/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/23/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/23/2015

ACEC

AMENDMENT FROM APPLICANT ENTERED

03/19/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/19/2015

ALIE

ASSIGNED TO LIE

03/12/2015

MAIL

PAPER RECEIVED

03/04/2015

CNRT

NON-FINAL ACTION MAILED

12/12/2014

CNRT

NON-FINAL ACTION WRITTEN

12/12/2014

DOCK

ASSIGNED TO EXAMINER

12/12/2014

MPMK

NOTICE OF PSEUDO MARK MAILED

09/12/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/11/2014

NWAP

NEW APPLICATION ENTERED

09/02/2014

Continuous trademark protection

Get notified about every new filing that threatens CALIBER I.D. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.